Skip to main content

Featured Stories

Conference Insider
April 22, 2021
A chronic disease’s estimated annual cost varies depending on the method used to arrive at the calculation, with inconsistent differences across diseases.
Conference Insider
April 22, 2021
“Asthma continues to be a disease with significant burden in the United States, and economic impact is significantly associated with asthma severity…
Interview
April 21, 2021
Annie Yan, PharmD, manager of value…
News
April 21, 2021
“Because persistence with the same anti-TNF drug in second-line treatment decreases the overall disease-associated costs compared with non-…
News
April 21, 2021
Researchers recently conducted a network meta-analysis and found treatment with guselkumab for psoriatic arthritis improved patient outcomes.
Conference Insider
April 21, 2021
Researchers recently advised that a unique criterion and process must be used to evaluate drugs for placement in a value-based formulary.
Conference Insider
April 21, 2021
Researchers presented data at AMCP 2021 on the effectiveness of physician follow-up phone calls compared to letters in an effort to reduce drug-…
News
April 20, 2021
Humana sharply disputed the findings of the audit, and a spokesperson for the company said Humana will work with Medicare officials “to resolve this…
Conference Insider
April 19, 2021
“Although increases in utilization and cost to the plan were observed for many policies deemed appropriately archived, it was determined that the…
Back to Top